Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell, Marginal Zone × Cisplatin × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 41 Lung Neoplasms 25 Squamous Cell Carcinoma of Head and Neck 22 Urinary Bladder Neoplasms 10 Carcinoma 10 Oropharyngeal Neoplasms 8 Neoplasm Metastasis 8 Nasopharyngeal Carcinoma 8 Colorectal Neoplasms 8 Uterine Cervical Neoplasms 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 7 Ovarian Neoplasms 7 Laryngeal Neoplasms 7 Stomach Neoplasms 6 Mouth Neoplasms 6 Head and Neck Neoplasms 6 Esophageal Squamous Cell Carcinoma 6 Neoplasms 5 Esophageal Neoplasms 5 Biliary Tract Neoplasms 5 Mesothelioma, Malignant 4 Hypopharyngeal Neoplasms 4 Gallbladder Neoplasms 4 Cholangiocarcinoma 4 Carcinoma, Transitional Cell 4 Carcinoma, Squamous Cell 4 Triple Negative Breast Neoplasms 3 Rectal Neoplasms 3 Lymphoid Interstitial Pneumonia 3 Endometrial Neoplasms 3

Interventions

Rituximab 11 Cyclophosphamide 7 Lenalidomide 5 zanubrutinib 4 venetoclax 4 Vincristine 4 orelabrutinib 3 fludarabine 3 Prednisone 3 Doxorubicin 3 CT-P10 3 pirtobrutinib 2 obinutuzumab 2 fludarabine phosphate 2 Whole-Body Irradiation 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 Cyclosporine 2 voruciclib 1 treosulfan 1 tislelizumab 1 prednylidene 1 pembrolizumab 1 ixazomib 1 ibrutinib 1 glofitamab 1 deltacortene 1 cc-486 1 Stem Cell Transplantation 1 Radiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡